Literature DB >> 18852663

Octreotide attenuates impaired microcirculation in postischemic pancreatitis when administered before induction of ischemia.

Guido Woeste1, Christoph Wullstein, Sebastian Meyer, Klaus H Usadel, Ulrich T Hopt, Wolf O Bechstein, Ernst von Dobschuetz.   

Abstract

BACKGROUND: Ischemia-reperfusion injury of the pancreas causes impairment of microcirculation leading to pancreatitis. Postischemic pancreatitis is the most common reason for graft failure in pancreas transplantation. In animal models, octreotide has been described to have beneficial effects on acute pancreatitis by reducing pancreatic enzyme release and edema formation by preventing the increase of macromolecular extravasation. In contrast to earlier experimental setups, this study investigated the influence of octreotide on ischemia-reperfusion pancreatitis when administered before induction of ischemia.
METHODS: Sprague-Dawley rats were randomly assigned to three groups: (1) sham-operated animals (sham group, n=7); (2) 1 hr ischemia followed by 1 hr reperfusion (control group, n=7); (3) administration of 50 microg/kg octreotide intravenously 15 min before ischemia (octreotide group, n=7). At the end of reperfusion, intravital fluorescence microscopy was performed assessing the functional capillary density (FCD), leukocyte-endothelium interaction (LEI), and the microvascular permeability. Finally serum amylase and lipase were measured.
RESULTS: The application of octreotide significantly reduced the ischemia-reperfusion-induced reduction of FCD (318.4+/-44.1 cm/cm vs. 257.4+/-11.7 cm/cm, P<0.001). The increase of LEI due to ischemia-reperfusion (466.9+/-52.2 cells/mm) was reduced in the octreotide group (264.4+/-55.1, P=0.001). Permeability was significantly lower in the octreotide group (0.56+/-0.57x10 cm/sec vs. 2.2.1+/-0.54x10 cm/sec, P<0.001). The level of serum lipase was reduced significantly after octreotide therapy (72.4+/-53.4 U/L vs. 136.7+/-66.5 U/L, P=0.026).
CONCLUSION: Octreotide significantly attenuated pancreatic dysfunction caused by ischemia-reperfusion when given before ischemia. Furthermore, we could prove for the first time a beneficial role of octreotide on preservation of the microvascular barrier for macromolecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852663     DOI: 10.1097/TP.0b013e318186b783

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Study on acute recent stage pancreatitis.

Authors:  Ye-Chen Feng; Min Wang; Feng Zhu; Ren-Yi Qin
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

2.  Effects of intravenous administration of pentoxifylline in pancreatic ischaemia-reperfusion injury.

Authors:  Edmond Raymond Le Campion; Jose Jukemura; Ana Maria Coelho; Rosely Patzina; Luiz Augusto Carneiro D'Albuquerque
Journal:  HPB (Oxford)       Date:  2012-12-17       Impact factor: 3.647

3.  Effects of diclofenac sodium and octreotide on treatment of caerulein-induced acute pancreatitis in mice.

Authors:  Ozlem Ozer Cakir; Hasan Esen; Aysun Toker; Huseyin Ataseven; Ali Demir; Hakki Polat
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Pretreatment of cisplatin in recipients attenuates post-transplantation pancreatitis in murine model.

Authors:  Sheng Yan; Yuan Ding; Fei Sun; Zhongjie Lu; Liang Xue; Xiangyan Liu; Mingqi Shuai; Chen Fang; Yan Wang; Hui Cheng; Lin Zhou; Ming H Zheng; Shusen Zheng
Journal:  Int J Biol Sci       Date:  2012-02-01       Impact factor: 6.580

5.  Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model.

Authors:  Meng Tao Zhou; Bi Cheng Chen; Hong Wei Sun; Yue Peng Jin; Fa Jing Yang; Xing Zhang; Roland Andersson; Qi Yu Zhang
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.